nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.0274	0.0274	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0237	0.0237	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0234	0.0234	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0216	0.0216	CbGpPWpGaD
Procyclidine—CHRM4—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0206	0.0206	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0165	0.0165	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0146	0.0146	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0145	0.0145	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0144	0.0144	CbGpPWpGaD
Procyclidine—CHRM1—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0139	0.0139	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0138	0.0138	CbGpPWpGaD
Procyclidine—CHRM2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0137	0.0137	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0131	0.0131	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0119	0.0119	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0111	0.0111	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0111	0.0111	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.011	0.011	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00998	0.00998	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00921	0.00921	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00903	0.00903	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00884	0.00884	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00881	0.00881	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00872	0.00872	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00866	0.00866	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00866	0.00866	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00855	0.00855	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00852	0.00852	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00846	0.00846	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00844	0.00844	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.0081	0.0081	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00804	0.00804	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00799	0.00799	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00797	0.00797	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00789	0.00789	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00732	0.00732	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00689	0.00689	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00689	0.00689	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00673	0.00673	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00671	0.00671	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00664	0.00664	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00659	0.00659	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00617	0.00617	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00613	0.00613	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00609	0.00609	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00607	0.00607	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00606	0.00606	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00601	0.00601	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00594	0.00594	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00576	0.00576	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00576	0.00576	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00576	0.00576	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00575	0.00575	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0057	0.0057	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00569	0.00569	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00568	0.00568	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00563	0.00563	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00558	0.00558	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00551	0.00551	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00546	0.00546	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00544	0.00544	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00542	0.00542	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0054	0.0054	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00539	0.00539	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00535	0.00535	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00524	0.00524	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00524	0.00524	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00524	0.00524	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00512	0.00512	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00499	0.00499	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00494	0.00494	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00492	0.00492	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00487	0.00487	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00472	0.00472	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00464	0.00464	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00464	0.00464	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00463	0.00463	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00463	0.00463	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00463	0.00463	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00458	0.00458	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00458	0.00458	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00439	0.00439	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00416	0.00416	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00414	0.00414	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0041	0.0041	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00399	0.00399	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00395	0.00395	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00376	0.00376	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00375	0.00375	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00371	0.00371	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00371	0.00371	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0037	0.0037	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00367	0.00367	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00359	0.00359	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.00358	0.00358	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00354	0.00354	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00354	0.00354	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00353	0.00353	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00352	0.00352	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00352	0.00352	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00352	0.00352	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00349	0.00349	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00349	0.00349	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00349	0.00349	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00345	0.00345	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00344	0.00344	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00341	0.00341	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00337	0.00337	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00336	0.00336	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00332	0.00332	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00318	0.00318	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00317	0.00317	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00316	0.00316	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00315	0.00315	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00314	0.00314	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00312	0.00312	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00311	0.00311	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00308	0.00308	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00304	0.00304	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00303	0.00303	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00303	0.00303	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00296	0.00296	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00296	0.00296	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00286	0.00286	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00274	0.00274	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00269	0.00269	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00269	0.00269	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00269	0.00269	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00268	0.00268	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00266	0.00266	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00242	0.00242	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00242	0.00242	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00239	0.00239	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.00231	0.00231	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00225	0.00225	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00222	0.00222	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00213	0.00213	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00213	0.00213	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00213	0.00213	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00212	0.00212	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00211	0.00211	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0021	0.0021	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00205	0.00205	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00204	0.00204	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00204	0.00204	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00203	0.00203	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00203	0.00203	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00203	0.00203	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00202	0.00202	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00201	0.00201	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00201	0.00201	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.002	0.002	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.002	0.002	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00199	0.00199	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00199	0.00199	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00197	0.00197	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00197	0.00197	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00193	0.00193	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00192	0.00192	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00191	0.00191	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00187	0.00187	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00186	0.00186	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00185	0.00185	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00184	0.00184	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00184	0.00184	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00182	0.00182	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00181	0.00181	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00181	0.00181	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00181	0.00181	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00181	0.00181	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00179	0.00179	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00179	0.00179	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00169	0.00169	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00159	0.00159	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00159	0.00159	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.00154	0.00154	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00152	0.00152	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00152	0.00152	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.0015	0.0015	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0015	0.0015	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00149	0.00149	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00148	0.00148	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00146	0.00146	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00145	0.00145	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00138	0.00138	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00138	0.00138	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00137	0.00137	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00137	0.00137	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00136	0.00136	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00136	0.00136	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00136	0.00136	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00135	0.00135	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00134	0.00134	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00126	0.00126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00126	0.00126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00124	0.00124	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00124	0.00124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00124	0.00124	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00123	0.00123	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00121	0.00121	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00119	0.00119	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00117	0.00117	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00114	0.00114	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00114	0.00114	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00113	0.00113	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00109	0.00109	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00106	0.00106	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00106	0.00106	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000815	0.000815	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000813	0.000813	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000805	0.000805	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000803	0.000803	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000801	0.000801	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000793	0.000793	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000791	0.000791	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000789	0.000789	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000781	0.000781	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000735	0.000735	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000732	0.000732	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000725	0.000725	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000719	0.000719	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000716	0.000716	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000709	0.000709	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000629	0.000629	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000626	0.000626	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000624	0.000624	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000424	0.000424	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000423	0.000423	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000422	0.000422	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000421	0.000421	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000419	0.000419	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000417	0.000417	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00037	0.00037	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000249	0.000249	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000249	0.000249	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000246	0.000246	CbGpPWpGaD
